Culture-modified bone marrow cells attenuate cardiac and renal injury in a chronic kidney disease rat model via a novel antifibrotic mechanism.
Most forms of chronic kidney disease are characterized by progressive renal and cardiac fibrosis leading to dysfunction. Preliminary evidence suggests that various bone marrow-derived cell populations have antifibrotic effects. In exploring the therapeutic potential of bone marrow derived cells in c...
Main Authors: | Darren A Yuen, Kim A Connelly, Andrew Advani, Christine Liao, Michael A Kuliszewski, Judy Trogadis, Kerri Thai, Suzanne L Advani, Yuan Zhang, Darren J Kelly, Howard Leong-Poi, Armand Keating, Philip A Marsden, Duncan J Stewart, Richard E Gilbert |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2010-03-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC2832011?pdf=render |
Similar Items
-
Fluorescent microangiography is a novel and widely applicable technique for delineating the renal microvasculature.
by: Andrew Advani, et al.
Published: (2011-01-01) -
Repeated Treatment with Bone Marrow Cell Secretory Products Maintains Long-Term Renoprotection in Experimental Chronic Kidney Disease: A Placebo-Controlled Trial
by: Darren A. Yuen, et al.
Published: (2015-11-01) -
SDF-1/CXCR4 signaling preserves microvascular integrity and renal function in chronic kidney disease.
by: Li-Hao Chen, et al.
Published: (2014-01-01) -
Progenitor cell secretory products exert additive renoprotective effects when combined with ace inhibitors in experimental CKD
by: David M Kepecs, et al.
Published: (2016-09-01) -
Antifibrotics in India
by: Raja Dhar
Published: (2019-01-01)